Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Randomized, Controlled, Latin-square, Open-label Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants

NCT07446881 is registered in ClinicalTrials.gov with Advicenne Pharma as lead sponsor.

NCT NCT07446881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07446881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Randomized, Controlled, Latin-square, Open-label Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants
Lead sponsor
Advicenne Pharma
Phase
Phase 1
Overall status
Completed
Start date
February 25, 2025
Completion date
March 15, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

distal renal tublular acidosis, effect of adv7103 on gastric ph